Male Pattern Hair Loss
In recent years, low-level laser/light therapy (LLLT), or photobiomodulation or photobiostimulation, has been promoted to prevent hair loss and stimulate hair growth in MPHL. REVIAN is a mobile soft dome shaped cap using LED modulated light therapy which is controlled and operated by a mobile app and is intended to be used in a home environment.
This 26 week, prospective sponsored clinical trial will investigate the safety and efficacy of REVIAN in male participants aged 18 – 60 years old who:
- Have Androgenic Alopecia, Norwood Hamilton scales of IIa – V and Fitzpatrick skin type I – IV
- Have never taken or stopped taking Propecia for 12 months prior to enrolment
- Have never used or stopped using Topical or Oral Minoxidil for at 6 months prior to enrolment
- Have not had previous hair transplant, cell treatment, micro-needling, tattooing, or any other treatment to the scalp
Patients will be randomized to 1 of 3 active treatment arms or a sham. There are 4 visits over 26 weeks. All treatments are provided free of charge. Other inclusion and exclusion criteria apply.
Patients will be reimbursed for travel costs.